Call for Proposals: High-Impact International Trials

Background:

One of the key objectives of the ACT Consortium is to expand Canadian participation in international trials. This new funding opportunity is designed to:

(1) support ongoing and active, internationally led, high-impact randomized controlled trials (RCTs);

(2) bring such trials to Canada so Canadian patients can have access to participate; and

(3) have National Canadian Principal Investigators and Canadian Site Investigators contribute to an important internationally led trial and build international collaborations.

Applicants can request up to $200,000 to support the recruitment of Canadian participants in their high-impact, ongoing international RCT.  

Eligibility:

• The Overall Trial PI must be located in a country outside of Canada, and must be collaborating with designated National Canadian PI who is a member of an ACT Network
• The application must be endorsed by one of ACT’s 34 Networks (click here to see the full list of ACT Networks)
• The trial must be ongoing and active outside of Canada
• The trial must plan to complete recruitment and follow-up of Canadian patients related to the ACT funding of this trial by June 30, 2026

Deadline:

The deadline to apply is Monday September 30th, 2024 at noon ET